LTFS
CCXI

Ladenburg Thalmann Financial Services’s ChemoCentryx, Inc. CCXI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-667
Closed -$6K – 5537
2019
Q2 		$6K Buy
667
+177
+36% +$2.05K ﹤0.01% 4673
2019
Q1 		$7K Hold
490
– – ﹤0.01% 4557
2018
Q4 		$5K Buy
+490
New +$5.17K ﹤0.01% 4631
2014
Q4 		– Sell
-44
Closed – – 4469
2014
Q3 		$0 Hold
44
– – ﹤0.01% 4077
2014
Q2 		$0 Buy
+44
New +$247 ﹤0.01% 4006

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CCXI Position: Q3 2019 in Review

Ladenburg Thalmann Financial Services sold out of ChemoCentryx, Inc. (CCXI) in Q3 2019, closing a stake of 667 shares — an estimated $6K sold.

Ladenburg Thalmann Financial Services first reported a position in CCXI in Q2 2014 and held it in 5 quarters. The position peaked at $7K in Q1 2019. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

  • Ladenburg Thalmann Financial Services reported no remaining ChemoCentryx, Inc. position as of Q3 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 667 ChemoCentryx, Inc. shares in Q3 2019, an estimated $6K.
  • Ladenburg Thalmann Financial Services first reported a position in ChemoCentryx, Inc. in Q2 2014 and held it in 5 quarters.
  • Ladenburg Thalmann Financial Services's ChemoCentryx, Inc. position peaked at $7K in Q1 2019.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2019, filed 14 Nov 2019.